• Explore /
  • Poster
  • / The impact of multimodality therapies in marginally inoperable soft tissue sarcomas (STS): The Toronto Sarcoma Program (TSP) experience.

The impact of multimodality therapies in marginally inoperable soft tissue sarcomas (STS): The Toronto Sarcoma Program (TSP) experience.

Abstract Poster

Authors

Olga Vornicova

Olga Vornicova

Department of Medical Oncology, Princess Margaret Cancer Centre, Toronto, ON, Canada

Olga Vornicova , Jay Wunder , Peter W. M. Chung , Abha A. Gupta , Rebecca Anne Gladdy , Charles N. Catton , Samer Salah , Peter Charles Ferguson , Kim Tsoi , David Benjamin Shultz , Savtaj Singh Brar , Philip Wong , Carol Jane Swallow , Albiruni Ryan Abdul Razak , Esmail Mutahar Al-Ezzi

Sign-In to See More Abstracts, Journal Articles, Posters, Videos and Slides and to Bookmark Your Favorite Content.

Disclaimer

This material on this page is ©2024 American Society of Clinical Oncology, all rights reserved. Licensing available upon request. For more information, please contact licensing@asco.org

Poster Details

Meeting

2021 ASCO Annual Meeting

Session Type

Poster Session

Session Title

Sarcoma

Track

Sarcoma

Sub Track

Soft Tissue Tumors

Citation

J Clin Oncol 39, 2021 (suppl 15; abstr 11548)

DOI

10.1200/JCO.2021.39.15_suppl.11548

Abstract #

11548

Poster Bd #

Online Only

Abstract Disclosures

Similar Posters

First Author: Samer Salah

First Author: Danielle Klingberg

First Author: Gerges Attia Demian

First Author: T. Schmitt